|[May 02, 2013]
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results
PASADENA, Calif. --(Business Wire)--
Arrowhead Research Corporation (NASDAQ:ARWR), a targeted therapeutics
company, today announced that it will report its financial results for
the fiscal 2013 second quarter ended March 31, 2013, on Thursday, May 9,
2013, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate
in the conference call, please dial 877-317-6789 (toll free from the
US), 866-605-3852 (toll free from Canada), or 412-317-6789 (for
international callers). Investors may also access a live audio webcast
of this conference call on the Company's website at www.arrowheadresearch.com.
A replay of the webcast will be available approximately two hours after
the conclusion of the call and will remain available for 90 days. An
audi replay will also be available approximately one hour after the
conclusion of the call and will be available for 30 days. The audio
replay can be accessed by dialing 877-870-5176 (toll free from the US
and Canada), or 858-384-5517 (for international callers) and entering
Event ID 10028640.
About Arrowhead Research Corporation
Arrowhead Research Corporation is a clinical stage targeted therapeutics
company with development programs in oncology, obesity, and chronic
hepatitis B virus infection. The company is leveraging its platform
technologies to design and develop peptide-drug conjugates (PDCs) that
specifically home to cell types of interest while sparing off-target
tissues, create targeted drugs based on the gene silencing RNA
interference (RNAi) mechanism, and work with partners to create improved
versions of traditional small molecule drugs.
For more information please visit http://www.arrowheadresearch.com,
or follow us on Twitter (News - Alert) @ArrowRes.
To be added to the Company's email list to receive news directly, please
send an email to email@example.com.
[ InfoTech Spotlight's Homepage ]